In summary, despite the limited number of samples, normal tissues, and limited clinical data available, we have shown that feline thyroid tumors, similarly to human thyroid tumors, are characterized by the activation of MAPK- and mTOR-signaling pathways, but lack mutations occurring in the most common hotspots of BRAF and RAS. The gene discussed is BRAF; the disease is thyroid tumor.